These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
102 related articles for article (PubMed ID: 2818643)
21. Biotransformation of 1-nitropyrene to 1-aminopyrene and N-formyl-1-aminopyrene by the human intestinal microbiota. Manning BW; Cerniglia CE; Federle TW J Toxicol Environ Health; 1986; 18(3):339-46. PubMed ID: 3519993 [TBL] [Abstract][Full Text] [Related]
22. [Hydroxylamino- and nitrosobiphenyl: biological oxidation products of 4-aminobiphenyl and intermediates of 4-nitrobiphenyl reduction]. Uehleke H; Nestel K Naunyn Schmiedebergs Arch Exp Pathol Pharmakol; 1967; 257(2):151-71. PubMed ID: 4385670 [No Abstract] [Full Text] [Related]
23. DNA binding by 1-nitropyrene and dinitropyrenes in vitro and in vivo: effects of nitroreductase induction. Beland FA Res Rep Health Eff Inst; 1989 Nov; (31):1-16. PubMed ID: 2604921 [TBL] [Abstract][Full Text] [Related]
24. Radical accumulation in liver microsomal membranes during biotransformation of aromatic amines and nitro compounds. Stier A; Beitz I; Sackmann E Naunyn Schmiedebergs Arch Pharmacol; 1972; 274(2):189-91. PubMed ID: 4340796 [No Abstract] [Full Text] [Related]
25. Binding of nitrobenzene to hepatic DNA and hemoglobin at low doses in mice. Li H; Wang H; Sun H; Liu Y; Liu K; Peng S Toxicol Lett; 2003 Mar; 139(1):25-32. PubMed ID: 12595155 [TBL] [Abstract][Full Text] [Related]
26. Contribution of intestinal microfloral metabolism to the total macromolecular covalent binding of 1-nitro-pyrene in the lung and liver of the rat. Ayres PH; Sun JD; Bond JA Toxicology; 1985 Aug; 36(2-3):263-73. PubMed ID: 3840295 [TBL] [Abstract][Full Text] [Related]
27. Biomonitoring of aniline and nitrobenzene. Hemoglobin binding in rats and analysis of adducts. Albrecht W; Neumann HG Arch Toxicol; 1985 Apr; 57(1):1-5. PubMed ID: 4015392 [TBL] [Abstract][Full Text] [Related]
28. Nitroreduction and formation of hemoglobin adducts in rats with a human intestinal microflora. Scheepers PT; Straetemans MM; Koopman JP; Bos RP Environ Health Perspect; 1994 Oct; 102 Suppl 6(Suppl 6):39-41. PubMed ID: 7889856 [TBL] [Abstract][Full Text] [Related]
29. Metabolism of K-region derivatives of 1-nitropyrene by rat liver in vitro. Roy AK; el-Bayoumy K; Hecht SS Carcinogenesis; 1988 Feb; 9(2):255-8. PubMed ID: 3338108 [TBL] [Abstract][Full Text] [Related]
30. DNA binding by 1-nitropyrene and 1,6-dinitropyrene in vitro and in vivo: effects of nitroreductase induction. Djurić Z; Fifer EK; Yamazoe Y; Beland FA Carcinogenesis; 1988 Mar; 9(3):357-64. PubMed ID: 3345577 [TBL] [Abstract][Full Text] [Related]
31. Comparison of the in vitro and in vivo N-oxidation of the carcinogenic aromatic amines. Brill E; Radomski JL Xenobiotica; 1971; 1(4):347-8. PubMed ID: 5164813 [No Abstract] [Full Text] [Related]
32. Bioactivation of 2-nitrofluorene to reactive intermediates that bind covalently to DNA, RNA and protein in vitro and in vivo in the rat. Wierckx FC; Wedzinga R; Meerman JH; Mulder GJ Carcinogenesis; 1990 Jan; 11(1):27-32. PubMed ID: 1688520 [TBL] [Abstract][Full Text] [Related]
33. Biomonitoring of nitropolynuclear aromatic hydrocarbons via protein and DNA adducts. el-Bayoumy K; Johnson BE; Roy AK; Upadhyaya P; Partian SJ Res Rep Health Eff Inst; 1994 Apr; (64):1-27; discussion 29-37. PubMed ID: 8037891 [TBL] [Abstract][Full Text] [Related]
34. N-oxidation of certain aromatic amines, acetamides, and nitro compounds by monkeys and dogs. Radomski JL; Conzelman GM J Natl Cancer Inst; 1973 Apr; 50(4):989-95. PubMed ID: 4634087 [No Abstract] [Full Text] [Related]
35. Metabolic activation of aromatic amines by human pancreas. Anderson KE; Hammons GJ; Kadlubar FF; Potter JD; Kaderlik KR; Ilett KF; Minchin RF; Teitel CH; Chou HC; Martin MV; Guengerich FP; Barone GW; Lang NP; Peterson LA Carcinogenesis; 1997 May; 18(5):1085-92. PubMed ID: 9163700 [TBL] [Abstract][Full Text] [Related]
36. Metabolism and DNA binding of 2-nitropyrene in the rat. Upadhyaya P; Roy AK; Fu PP; el-Bayoumy K Cancer Res; 1992 Mar; 52(5):1176-81. PubMed ID: 1737377 [TBL] [Abstract][Full Text] [Related]
38. CYP1A2 and NAT2 phenotyping and 3-aminobiphenyl and 4-aminobiphenyl hemoglobin adduct levels in smokers and non-smokers. Sarkar M; Stabbert R; Kinser RD; Oey J; Rustemeier K; von Holt K; Schepers G; Walk RA; Roethig HJ Toxicol Appl Pharmacol; 2006 Jun; 213(3):198-206. PubMed ID: 16405939 [TBL] [Abstract][Full Text] [Related]
39. Identification of DNA adducts using HPLC/MS/MS following in vitro and in vivo experiments with arylamines and nitroarenes. Jones CR; Sabbioni G Chem Res Toxicol; 2003 Oct; 16(10):1251-63. PubMed ID: 14565767 [TBL] [Abstract][Full Text] [Related]
40. Metabolic activation of carcinogenic heterocyclic aromatic amines by human liver and colon. Turesky RJ; Lang NP; Butler MA; Teitel CH; Kadlubar FF Carcinogenesis; 1991 Oct; 12(10):1839-45. PubMed ID: 1934265 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]